Kynurenine induces an age-related phenotype in bone marrow stromal cells

Mech Ageing Dev. 2021 Apr:195:111464. doi: 10.1016/j.mad.2021.111464. Epub 2021 Feb 22.

Abstract

Advanced age is one of the important contributing factors for musculoskeletal deterioration. Although the exact mechanism behind this degeneration is unknown, it has been previously established that nutritional signaling plays a vital role in musculoskeletal pathophysiology. Our group established the vital role of the essential amino acid, tryptophan, in aging musculoskeletal health. With advanced age, inflammatory factors activate indoleamine 2,3-dioxygenase (IDO1) and accumulate excessive intermediate tryptophan metabolites such as Kynurenine (KYN). With age, Kynurenine accumulates and suppresses osteogenic differentiation, impairs autophagy, promotes early senescence, and alters cellular bioenergetics of bone marrow stem cells. Recent studies have shown that Kynurenine negatively impacts bone marrow stromal cells (BMSCs) and, consequently, promotes bone loss. Overall, understanding the mechanism behind BMSCs losing their ability for osteogenic differentiation can provide insight into the prevention of osteoporosis and the development of targeted therapies. Therefore, in this article, we review Kynurenine and how it plays a vital role in BMSC dysfunction and bone loss with age.

Keywords: Aging; Bone marrow stromal cells; Kynurenine.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Autophagy
  • Bone Marrow Cells / physiology*
  • Cellular Senescence
  • Humans
  • Kynurenine / metabolism*
  • Musculoskeletal Physiological Phenomena*
  • Osteogenesis / physiology
  • Osteoporosis* / metabolism
  • Osteoporosis* / prevention & control
  • Signal Transduction
  • Stromal Cells / physiology*
  • Tryptophan / metabolism*

Substances

  • Kynurenine
  • Tryptophan